Notably, STAR + cells in chemotherapy-sensitive patients exhibited higher enrichment in these pathways compared to resistant patients, suggesting that STAR + cells may enhance chemotherapy efficacy by regulating metabolic processes that increase tumor vulnerability to platinum-based drugs. The gene discussed is STAR; the disease is neoplasm.